Global Lyme Disease Testing Competitive Landscape Professional Research Report 2025

Research Summary

Lyme disease testing refers to the diagnostic procedures used to detect the presence of Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi. The primary method of Lyme disease testing involves serological tests that detect antibodies produced by the immune system in response to the infection. The most common serological tests include the enzyme immunoassay (EIA) and the Western blot test. The EIA is typically used as a screening test and if positive or equivocal, the Western blot test is performed to confirm the diagnosis. These tests detect specific antibodies against the Lyme disease bacteria. However, it is essential to note that the accuracy of these tests can vary, and false-negative results are possible, especially during the early stages of infection when antibody levels may be low. In some cases, additional laboratory tests, such as polymerase chain reaction (PCR) testing or culture of the bacteria, may be used to directly detect the presence of the bacterium in blood, joint fluid, or tissues. The interpretation of test results should be done in conjunction with clinical symptoms and exposure history to ensure accurate diagnosis and appropriate treatment of Lyme disease. Consulting with a healthcare professional is crucial for proper testing and interpretation.

According to DIResearch's in-depth investigation and research, the global Lyme Disease Testing market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size has reached XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global suppliers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), Bio-Rad Laboratories, BioMerieux, T1 Biosystems, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Lyme Disease Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Lyme Disease Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Lyme Disease Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Lyme Disease Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Lyme Disease Testing Include:

Quidel Corporation

Roche Holding AG

Fujirebio(H.U. Group Holdings)

ZEUS Scientific

IGeneX

Thermo Fisher Scientific

Everlywell

Oxford Immunotec Global PLC(PerkinElmer)

Bio-Rad Laboratories

BioMerieux

T1 Biosystems

Lyme Disease Testing Product Segment Include:

ELISA

Western Blotting

PCR

Others

Lyme Disease Testing Product Application Include:

Hospital and Testing Agency

Personal

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Lyme Disease Testing Industry PESTEL Analysis

Chapter 3: Global Lyme Disease Testing Industry Porter’s Five Forces Analysis

Chapter 4: Global Lyme Disease Testing Major Regional Market Size and Forecast Analysis

Chapter 5: Global Lyme Disease Testing Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Lyme Disease Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global Lyme Disease Testing Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)

Table 2： Global Lyme Disease Testing Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)

Table 3： Lyme Disease Testing Industry Development Status

Table 4： Lyme Disease Testing Industry Development Trends

Table 5： Global Lyme Disease Testing Market Size by Region in US$ Million: 2024 VS 2025 VS 2032

Table 6： Global Lyme Disease Testing Revenue by Region (2020-2025) & (US$ Million)

Table 7： Global Lyme Disease Testing Revenue Market Share by Region (2020-2025)

Table 8： Global Lyme Disease Testing Revenue Forecast by Region (2026-2032) & (US$ Million)

Table 9： Global Lyme Disease Testing Revenue Market Share Forecast by Region (2026-2032)

Table 10： Global Lyme Disease Testing Revenue Analysis by Type (2020-2025) & (US$ Million)

Table 11： Global Lyme Disease Testing Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)

Table 12： Global Lyme Disease Testing Revenue Analysis by Application (2020-2025) & (US$ Million)

Table 13： Global Lyme Disease Testing Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)

Table 14： Key Lyme Disease Testing Players in North America

Table 15： North America Lyme Disease Testing Revenue by Type (2020-2025) & (US$ Million)

Table 16： North America Lyme Disease Testing Revenue by Type (2026-2032) & (US$ Million)

Table 17： North America Lyme Disease Testing Revenue by Application (2020-2025) & (US$ Million)

Table 18： North America Lyme Disease Testing Revenue by Application (2026-2032) & (US$ Million)

Table 19： North America Lyme Disease Testing Revenue Market Size by Country (2020-2025) & (US$ Million)

Table 20： North America Lyme Disease Testing Revenue Market Size by Country (2026-2032) & (US$ Million)

Table 21： Key Lyme Disease Testing Players in Europe

Table 22： Europe Lyme Disease Testing Revenue by Type (2020-2025) & (US$ Million)

Table 23： Europe Lyme Disease Testing Revenue by Type (2026-2032) & (US$ Million)

Table 24： Europe Lyme Disease Testing Revenue by Application (2020-2025) & (US$ Million)

Table 25： Europe Lyme Disease Testing Revenue by Application (2026-2032) & (US$ Million)

Table 26： Europe Lyme Disease Testing Revenue Market Size by Country (2020-2025) & (US$ Million)

Table 27： Europe Lyme Disease Testing Revenue Market Size by Country (2026-2032) & (US$ Million)

Table 28： Key Lyme Disease Testing Players in China

Table 29： China Lyme Disease Testing Revenue by Type (2020-2025) & (US$ Million)

Table 30： China Lyme Disease Testing Revenue by Type (2026-2032) & (US$ Million)

Table 31： China Lyme Disease Testing Revenue by Application (2020-2025) & (US$ Million)

Table 32： China Lyme Disease Testing Revenue by Application (2026-2032) & (US$ Million)

Table 33： Key Lyme Disease Testing Players in APAC (excl. China)

Table 34： APAC (excl. China) Lyme Disease Testing Revenue by Type (2020-2025) & (US$ Million)

Table 35： APAC (excl. China) Lyme Disease Testing Revenue by Type (2026-2032) & (US$ Million)

Table 36： APAC (excl. China) Lyme Disease Testing Revenue by Application (2020-2025) & (US$ Million)

Table 37： APAC (excl. China) Lyme Disease Testing Revenue by Application (2026-2032) & (US$ Million)

Table 38： APAC (excl. China) Lyme Disease Testing Revenue Market Size by Country (2020-2025) & (US$ Million)

Table 39： APAC (excl. China) Lyme Disease Testing Revenue Market Size by Country (2026-2032) & (US$ Million)

Table 40： Key Lyme Disease Testing Players in Latin America

Table 41： Latin America Lyme Disease Testing Revenue by Type (2020-2025) & (US$ Million)

Table 42： Latin America Lyme Disease Testing Revenue by Type (2026-2032) & (US$ Million)

Table 43： Latin America Lyme Disease Testing Revenue by Application (2020-2025) & (US$ Million)

Table 44： Latin America Lyme Disease Testing Revenue by Application (2026-2032) & (US$ Million)

Table 45： Latin America Lyme Disease Testing Revenue Market Size by Country (2020-2025) & (US$ Million)

Table 46： Latin America Lyme Disease Testing Revenue Market Size by Country (2026-2032) & (US$ Million)

Table 47： Key Lyme Disease Testing Players in Middle East & Africa

Table 48： Middle East & Africa Lyme Disease Testing Revenue by Type (2020-2025) & (US$ Million)

Table 49： Middle East & Africa Lyme Disease Testing Revenue by Type (2026-2032) & (US$ Million)

Table 50： Middle East & Africa Lyme Disease Testing Revenue by Application (2020-2025) & (US$ Million)

Table 51： Middle East & Africa Lyme Disease Testing Revenue by Application (2026-2032) & (US$ Million)

Table 52： Middle East & Africa Lyme Disease Testing Revenue Market Size by Country (2020-2025) & (US$ Million)

Table 53： Middle East & Africa Lyme Disease Testing Revenue Market Size by Country (2026-2032) & (US$ Million)

Table 54： Global Lyme Disease Testing Market Revenue by Key Suppliers (2021-2025) & (US$ Million)

Table 55： Global Lyme Disease Testing Revenue Market Share by Key Suppliers (2021-2025)

Table 56： Global Key Suppliers Headquarter Location and Key Area Sales

Table 57： Market Mergers & Acquisitions, Expansion

Table 58： Quidel Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 59： Quidel Corporation Lyme Disease Testing Product Portfolio

Table 60： Quidel Corporation Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 61： Roche Holding AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 62： Roche Holding AG Lyme Disease Testing Product Portfolio

Table 63： Roche Holding AG Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 64： Fujirebio(H.U. Group Holdings) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 65： Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio

Table 66： Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 67： ZEUS Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 68： ZEUS Scientific Lyme Disease Testing Product Portfolio

Table 69： ZEUS Scientific Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 70： IGeneX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 71： IGeneX Lyme Disease Testing Product Portfolio

Table 72： IGeneX Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 73： Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 74： Thermo Fisher Scientific Lyme Disease Testing Product Portfolio

Table 75： Thermo Fisher Scientific Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 76： Everlywell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 77： Everlywell Lyme Disease Testing Product Portfolio

Table 78： Everlywell Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 79： Oxford Immunotec Global PLC(PerkinElmer) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 80： Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio

Table 81： Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 82： Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 83： Bio-Rad Laboratories Lyme Disease Testing Product Portfolio

Table 84： Bio-Rad Laboratories Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 85： BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 86： BioMerieux Lyme Disease Testing Product Portfolio

Table 87： BioMerieux Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 88： T1 Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 89： T1 Biosystems Lyme Disease Testing Product Portfolio

Table 90： T1 Biosystems Lyme Disease Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2025)

Table 91： Lyme Disease Testing Typical Customer List

Table 92： Lyme Disease Testing Distributors List

Figure 1： Lyme Disease Testing Product Pictures

Figure 2： ELISA Picture Scope

Figure 3： Western Blotting Picture Scope

Figure 4： PCR Picture Scope

Figure 5： Others Picture Scope

Figure 6： Hospital and Testing Agency Picture Scope

Figure 7： Personal Picture Scope

Figure 8： Global Lyme Disease Testing Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)

Figure 9： Global Lyme Disease Testing Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)

Figure 10： Global Lyme Disease Testing Market Size by Region (2020-2032) & (US$ Million)

Figure 11： Global Lyme Disease Testing Market Share Scenario by Region in Percentage: 2025 Versus 2032

Figure 12： North America Lyme Disease Testing Market Size and Growth Rate (2020-2032) & (US$ Million)

Figure 13： North America Lyme Disease Testing Market Share by Players in 2024

Figure 14： North America Lyme Disease Testing Revenue Market Share by Type (2020-2032)

Figure 15： North America Lyme Disease Testing Revenue Market Share by Application (2020-2032)

Figure 16： US Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 17： Canada Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 18： Europe Lyme Disease Testing Market Size and Growth Rate (2020-2032) & (US$ Million)

Figure 19： Europe Lyme Disease Testing Market Share by Players in 2024

Figure 20： Europe Lyme Disease Testing Revenue Market Share by Type (2020-2032)

Figure 21： Europe Lyme Disease Testing Revenue Market Share by Application (2020-2032)

Figure 22： Germany Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 23： France Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 24： United Kingdom Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 25： Italy Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 26： Spain Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 27： Benelux Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 28： China Lyme Disease Testing Market Size and Growth Rate (2020-2032) & (US$ Million)

Figure 29： China Lyme Disease Testing Market Share by Players in 2024

Figure 30： China Lyme Disease Testing Revenue Market Share by Type (2020-2032)

Figure 31： China Lyme Disease Testing Revenue Market Share by Application (2020-2032)

Figure 32： APAC (excl. China) Lyme Disease Testing Market Size and Growth Rate (2020-2032) & (US$ Million)

Figure 33： APAC (excl. China) Lyme Disease Testing Market Share by Players in 2024

Figure 34： APAC (excl. China) Lyme Disease Testing Revenue Market Share by Type (2020-2032)

Figure 35： APAC (excl. China) Lyme Disease Testing Revenue Market Share by Application (2020-2032)

Figure 36： Japan Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 37： South Korea Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 38： India Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 39： Australia Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 40： Southeast Asia Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 41： Latin America Lyme Disease Testing Market Size and Growth Rate (2020-2032) & (US$ Million)

Figure 42： Latin America Lyme Disease Testing Market Share by Players in 2024

Figure 43： Latin America Lyme Disease Testing Revenue Market Share by Type (2020-2032)

Figure 44： Latin America Lyme Disease Testing Revenue Market Share by Application (2020-2032)

Figure 45： Mexico Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 46： Brazil Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 47： Middle East & Africa Lyme Disease Testing Market Size and Growth Rate (2020-2032) & (US$ Million)

Figure 48： Middle East & Africa Lyme Disease Testing Market Share by Players in 2024

Figure 49： Middle East & Africa Lyme Disease Testing Revenue Market Share by Type (2020-2032)

Figure 50： Middle East & Africa Lyme Disease Testing Revenue Market Share by Application (2020-2032)

Figure 51： Saudi Arabia Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 52： South Africa Lyme Disease Testing Revenue (2020-2032) & (US$ Million)

Figure 53： Global Lyme Disease Testing Revenue Market Share by Key Suppliers in 2024

Figure 54： Global Lyme Disease Testing Industry Competition Landscape

Figure 55： Lyme Disease Testing Industry Chain Analysis

Figure 56： Bottom-Up and Top-Down Research Methods

Figure 57： Key Interview Objectives

Figure 58： Data Cross Validation